Access and Benefit Sharing Under the Nagoya Protocol-Quo Vadis? Six Latin American Case Studies Assessing Opportunities and Risk.
Heinrich M, Scotti F, Andrade-Cetto A, Berger-Gonzalez M, Echeverría J, Friso F, Garcia-Cardona F, Hesketh A, Hitziger M, Maake C, Politi M, Spadafora C, Spadafora R.
Heinrich M, et al. Among authors: echeverria j.
Front Pharmacol. 2020 Jun 8;11:765. doi: 10.3389/fphar.2020.00765. eCollection 2020.
Front Pharmacol. 2020.
PMID: 32581783
Free PMC article.